[ WISE s.r.l raises $7.29M in Series B ]

WISE s.r.l has raised $7.29 million in Series B funding.

Founded in 2011, Wise s.r.l is a medical device company developing next-generation implantable neuromodulation. It develops novel, highly flexible and stretchable implantable neuromodulation leads for the treatment of a range of neurological conditions based on its proprietary Supersonic Cluster Beam Implantation technology.

By means of the new financial round, WISE aims to market its first product for acute use, Cortical Electrodes for intraoperative monitoring, and to conclude the development of its breakthrough product, the first percutaneously-implantable paddle lead for Spinal Cord Stimulation.

Funding  Series B
Founded  2011
Country  Italy
City  Milan
Founder / CEO  Luca Ravagnan
Deal Size  $7.29M
Investors  Principia SGR
 Antares
 High-Tech Gruenderfonds
 Atlante Ventures
 F3F
Previous Investors  btov Partners
 Atlante Seeds
 Agite!
 Amigdala
 High-Tech Gruenderfonds
 Antares Capital
 Principia SGR
 F3F
 Atlante Ventures